Antibe Therapeutics Inc., Safe Pain and Inflammation Medicine, CEO Clip Video

Vancouver, British Columbia--(Newsfile Corp. - September 13, 2017) - Dan Legault, CEO of Antibe Therapeutics Inc., on the company's best-in-class pain/inflammation and regenerative medicine divisions.

If you cannot view the video above, please visit:
http://www.b-tv.com/antibe-therapeutics-ceo-clip-90sec/

Antibe Therapeutics Inc. is being featured on CBC's Documentary Channel Sept. 18— Oct. 1, 2017 Monday through Friday, throughout the day and evenings.

Antibe Therapeutics Inc. (TSXV: ATE):

Antibe is a diversified biotechnology company with two best-in-class divisions in pain/inflammation and regenerative medicine. Its blockbuster drug platform has a lead asset in Phase 2, and the combined pipeline is targeting a global market opportunity in excess of $20 billion. Antibe's commercial division in regenerative medicine is on a global growth trajectory in the dental biologics market.

www.antibethera.com

About CEO Clips:

CEO Clips is the largest library of publicly traded company CEO videos in the US and Canada.  These 90 second video profiles broadcast on national TV and are distributed online on top financial portals including: Thomson Reuters, BNN.ca, and Stockhouse.com.  They are also disseminated via a video news release to several financial portals including Globe Investor, OTC Markets, TMX Money, and The National Post.

BTV — Business Television/CEO Clip Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com